PTEROIC ACID

CAS No. 119-24-4

PTEROIC ACID( —— )

Catalog No. M23003 CAS No. 119-24-4

Pteroic acid is part of the structure of folic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PTEROIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    Pteroic acid is part of the structure of folic acid.
  • Description
    Pteroic acid is part of the structure of folic acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119-24-4
  • Formula Weight
    312.28
  • Molecular Formula
    C14H12N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC(=CC=C1C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ke C Y , Mathias C J , Green M A . Targeting the Tumor-Associated Folate Receptor with an 111 InDTPA Conjugate of Pteroic Acid[J]. Journal of the American Chemical Society, 2005, 127(20):7421-7426.
molnova catalog
related products
  • 16 alpha-Hydroxytram...

    16 alpha-Hydroxytrametenolic acid can inhibit 12-O-tetradecanoylphorbol 13-acetate (TAP)-induced mouse ear edema.

  • 4-O-METHYLDAVIDIGENI...

    4-O-METHYLDAVIDIGENIN

  • 8,9-epoxy-3,10-diiso...

    10-Isobutyryloxy-8,9-epoxythymol isobutyrate is a major constituent of Inula helenium and Inula royleana root cultures. 10-Isobutyryloxy-8,9-epoxythymol isobutyrate shows moderate antimicrobial activity against Staphylococcus aureus FDA 209 P, Staphylococcus aureus, Enterococcus faecalis,Candida albicans and Pseudomonas aeruginosa with MICs of 50, 250, 250, 250, and 1000 μg/mL, respectively.